Skip Navigation

European Heart Journal 2000 21(13):1034-1036; doi:10.1053/euhj.2000.2111
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mahon, N.
Right arrow Articles by Mckenna, W.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahon, N.
Right arrow Articles by Mckenna, W.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Digoxin-like immunoreactive substances in hypertrophic cardiomyopathy

N. Mahon and W.J. Mckenna

St. George's Hospital Medical School, London, U.K.

References

  1. Kelly RA, Smith TW. Is ouabain the endogenous digitalis. Circulation. 1992;86:694–697[Free Full Text]
  2. Gruber KA, Whitaker JM, Buckalew VM Jr. Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature. 1980;287:743–745[CrossRef][Medline]
  3. de Wardener HE, MacGregor GA. The natriuretic hormone and essential hypertension. Lancet. 1982;1:1450–1454[Medline]
  4. Graves SW, Williams GH. Endogenous digitalis-like natriuretic factors. Ann Rev Med. 1987;38:433–444[CrossRef][ISI][Medline]
  5. Hamlyn JM, Harris DW, Clark MA, Rogowski AC, White RJ, Ludens JH. Isolation and characterization of a sodium pump inhibitor from human plasma. Hypertension. 1989;13:681–689[Abstract/Free Full Text]
  6. Hamlyn JM, Hamilton BP, Manunta P. Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J Hypertens. 1996;14:151–167[CrossRef][ISI][Medline]
  7. de The H, Devynck MA, Rosenfeld J, Pernollet MG, Elghozi JL, Meyer P. Plasma sodium pump inhibitor in essential hypertension and normotensive subjects with hypertensive heredity. Journal of Cardiovascular Pharmacology. 1984;6:S49–S54[CrossRef][ISI][Medline]
  8. Bagrov AY, Fedorova OV, Maslova MN, Roukoyatkina NI, Ukhanova MV, Zhabko EP. Endogenous plasma Na, K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction. Cardiovasc Res. 1991;25:371–377[ISI][Medline]
  9. Pudek MR, Seccombe DW, Whitfield MF, Ling E. Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapy. N Engl J Med. 1983;308:904–905[ISI][Medline]
  10. Gottlieb SS, Rogowski AC, Weinberg M, Kirchten CM, Hamilton BP, Hamlyn JM. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation. 1992;86:420–425[Abstract/Free Full Text]
  11. Laredo J, Hamilton BP, Hamlyn JM. Secretion of endogenous ouabain from bovine adrenocortical cells: role of the zona glomerulosa and zona fasciculata. Biochem Biophys Res Comm. 1995;212:487–493[CrossRef][ISI][Medline]
  12. Yamada H, Ihara N, Takahashi H, Yoshimura M, Sano Y. Distribution of the endogenous digitalis-like substance (EDLS)-containing neurons labelled by digoxin antibody in hypothalamus and three circumventricular organs of dog and macaque. Brain Res. 1992;584:237–243[CrossRef][ISI][Medline]
  13. Hayashi T, Ijiri Y, Toko H. Increased digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathy. Eur Heart J. 1000;21:296–305
  14. Delva P, Devynck MA, Degan M. Correlations between plasma levels of an endogenous digitalis-like substance and haemodynamic parameters measured during cardiac catheterization. J Hypertens. 1988;6:S348–S350
  15. Watkins H, Seidman CE, Seidman JG, Feng HS, Sweeney HL. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action. J Clin Invest. 1996;98:2456–2461[ISI][Medline]
  16. Mahon NG, KcKenna WJ. Calcium channel blockers in cardiac failure. Prog Cardiovasc Dis. 1998;41:191–206[CrossRef][ISI][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mahon, N.
Right arrow Articles by Mckenna, W.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahon, N.
Right arrow Articles by Mckenna, W.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?